Evaluation of Neutrophil/Lymphocyte Ratio ,Platelet/Lymph... | NCT03630276

Studies
Evaluation of Neutrophil/Lymphocyte Ratio ,Platelet/Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsia

NCT03630276

Sponsor

Ain Shams University

Status

Unknown status

Last Update Posted

Aug 14, 2018Actual

Enrollment

111Estimated

Phase

Not Applicable

Conditions

Pre-Eclampsia

Interventions

Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP

Countries

Egypt

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Aug 2018

Overall Recruitment Status or Expanded Access Status

Unknown status

Last Known Status

Recruiting

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Aug 1, 2018Actual

Primary Completion Date

Aug 10, 2018Actual

Completion Date

Aug 10, 2018Estimated

First Submitted Date

Aug 10, 2018

First Submission Date that Met QC Criteria

Aug 10, 2018

First Posted Date

Aug 14, 2018Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Aug 10, 2018

Last Update Posted Date

Aug 14, 2018Actual

Oversight Module

Has Data Monitoring Committee (DMC)

Not provided

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

Evaluation of neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP as markers of severity of Pre-eclampsia

Detailed Description

Not provided

Design Module

Study Type

Interventional

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not Applicable

Interventional Study Design

Allocation

Biospecimen

No data available

No data is available for this block.

Enrollment

111Estimated

Arms/Interventions Module

Arm Groups

Label	Type	Intervention Names
Neutrophil/lymphocyte ratio	Other	Diagnostic Test: Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP
Platelet/lymphocyte ratio	Other	Diagnostic Test: Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP
CRP	Other	Diagnostic Test: Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP

Interventions

Name	Type	Description	Arm Group Labels	Other Names
Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP	Diagnostic Test	Lab	CRP Neutrophil/lymphocyte ratio Platelet/lymphocyte ratio

Measure	Description	Time Frame
PREECLAMPSIA		6months

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

- PREECLAMPSIA from 25_45years

Exclusion Criteria:

chronic diseases Primary hypertension

Accepts Healthy Volunteers

Yes

Sex

Female

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

25 Years

Maximum Age

45 Years

Standard Ages

Adult

Study Population

Not provided

Sampling Method

Not provided

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Not provided

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Shaza	Recruiting	Alexandria	Alex	12345	Egypt

Condition Browse Module

MeSH Terms

ID	Term
D011225	Pre-Eclampsia

Ancestor Terms

ID	Term
D046110	Hypertension, Pregnancy-Induced
D011248	Pregnancy Complications
D005261	Female Urogenital Diseases and Pregnancy Complications
D000091642	Urogenital Diseases

Browse Leaves

Not provided

Browse Branches

Not provided

Intervention Browse Module

MeSH Terms

ID	Term
D010976	Platelet Count

Ancestor Terms

ID	Term
D001772	Blood Cell Count
D002452	Cell Count
D003584	Cytological Techniques
D019411	Clinical Laboratory Techniques

Browse Leaves

Not provided

Browse Branches

Not provided